159 related articles for article (PubMed ID: 17179796)
1. F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.
Iagaru A; McDougall IR
Clin Nucl Med; 2007 Jan; 32(1):13-5. PubMed ID: 17179796
[TBL] [Abstract][Full Text] [Related]
2. Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
Ciarallo A; Marcus C; Taghipour M; Subramaniam RM
PET Clin; 2015 Apr; 10(2):265-78. PubMed ID: 25829091
[TBL] [Abstract][Full Text] [Related]
3. Unusual adrenal metastasis and abdominal carcinomatosis secondary to Hurthle cell carcinoma of the thyroid.
Namwongprom S; Núñez RF; Yeung HW; Kim EE; Macapinlac HA
Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):694-6. PubMed ID: 18058606
[TBL] [Abstract][Full Text] [Related]
4. Gallbladder carcinoma metastasizing to adrenal gland: a rare site demonstrated with (18)F-FDG PET/CT.
Sahoo MK; Sharma P; Suman S; Jain TK; Bal C; Kumar R
Clin Nucl Med; 2014 Feb; 39(2):184-5. PubMed ID: 23856827
[TBL] [Abstract][Full Text] [Related]
5. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of thyroidal metastasis from lung cancer by F-18 FDG PET scan.
Jackson RT; Sinha P; Conrad GR
Clin Nucl Med; 2008 Jul; 33(7):505-6. PubMed ID: 18580244
[TBL] [Abstract][Full Text] [Related]
7. F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer.
Iguchi T; Matsuoka J; Sato S; Okumura Y; Omori M; Mifune H; Akaki S; Kanazawa S
Clin Nucl Med; 2007 May; 32(5):361-2. PubMed ID: 17452862
[TBL] [Abstract][Full Text] [Related]
8. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
[TBL] [Abstract][Full Text] [Related]
9. Massive bilateral adrenal gland metastases from melanoma diagnosed by F18-FDG-PET/CT.
Bertagna F; Biasiotto G; Rodella C; Werner T; Giubbini R; Alavi A
Jpn J Radiol; 2009 Nov; 27(9):392-3. PubMed ID: 19943154
[TBL] [Abstract][Full Text] [Related]
10. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
Basu S; Alavi A
Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
[No Abstract] [Full Text] [Related]
11. Port-site metastasis after laparoscopic removal of an isolated adrenal metastasis in a patient with breast cancer detected with FDG PET/CT.
Kajáry K; Molnár P; Lengyel Z; Szakáll S
Clin Nucl Med; 2014 Feb; 39(2):203-5. PubMed ID: 24152655
[TBL] [Abstract][Full Text] [Related]
12. Unusual case of isolated parasellar metastasis from carcinoma of thyroid.
Malhotra G; Asopa RV; Sridhar E
Clin Nucl Med; 2013 Feb; 38(2):145-8. PubMed ID: 23334134
[TBL] [Abstract][Full Text] [Related]
13. F-18 FDG PET/CT in the management of thyroid cancer.
Iagaru A; Kalinyak JE; McDougall IR
Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
[TBL] [Abstract][Full Text] [Related]
14. CT and PET appearance of a pigmented "black" adrenal adenoma in a patient with lung cancer.
Prince EA; Yoo DC; DeLellis RA; Mayo-Smith WW
Clin Radiol; 2007 Dec; 62(12):1229-31. PubMed ID: 17981173
[No Abstract] [Full Text] [Related]
15. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
Kang KW; Kim SK; Kang HS; Lee ES; Sim JS; Lee IG; Jeong SY; Kim SW
J Clin Endocrinol Metab; 2003 Sep; 88(9):4100-4. PubMed ID: 12970270
[TBL] [Abstract][Full Text] [Related]
16. Metastasis to the thyroid from non-small cell carcinoma of the lung: findings in (18)F-FDG PET/CT study.
Agrawal K; Weaver J; Mohan HK
Endocrine; 2015 Mar; 48(2):720-1. PubMed ID: 24853886
[TBL] [Abstract][Full Text] [Related]
17. Can injection of pentagastrin stimulate the identification of metastases of medullary thyroid carcinoma by (18)F-FDG PET/CT?
Erdoğan MF; Demir O; Ozkan E; Küçük ON
Hell J Nucl Med; 2012; 15(2):155-6. PubMed ID: 22741153
[No Abstract] [Full Text] [Related]
18. Adrenal collision tumor diagnosed by F-18 fluorodeoxyglucose PET/CT.
Anderson SB; Webb MD; Banks KP
Clin Nucl Med; 2010 Jun; 35(6):414-7. PubMed ID: 20479588
[No Abstract] [Full Text] [Related]
19. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
Pryma DA; Schöder H; Gönen M; Robbins RJ; Larson SM; Yeung HW
J Nucl Med; 2006 Aug; 47(8):1260-6. PubMed ID: 16883003
[TBL] [Abstract][Full Text] [Related]
20. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Kim SJ; Lee TH; Kim IJ; Kim YK
Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
